188 related articles for article (PubMed ID: 35469435)
1. Immunophenotype of Lacrimal Glands in Graves Orbitopathy: Implications for the Pathogenesis of Th1 and Th17 Immunity.
Huang Y; Wu Y; Zhang S; Lu Y; Wang Y; Liu X; Zhong S; Wang Y; Li Y; Sun J; Fang S; Zhou H
Thyroid; 2022 Aug; 32(8):949-961. PubMed ID: 35469435
[No Abstract] [Full Text] [Related]
2. Regulation of Orbital Fibrosis and Adipogenesis by Pathogenic Th17 Cells in Graves Orbitopathy.
Fang S; Huang Y; Zhong S; Li Y; Zhang Y; Li Y; Sun J; Liu X; Wang Y; Zhang S; Xu T; Sun X; Gu P; Li D; Zhou H; Li B; Fan X
J Clin Endocrinol Metab; 2017 Nov; 102(11):4273-4283. PubMed ID: 28938397
[TBL] [Abstract][Full Text] [Related]
3. M1-Like Macrophages Modulate Fibrosis and Inflammation of Orbital Fibroblasts in Graves' Orbitopathy: Potential Relevance to Soluble Interleukin-6 Receptor.
Lu Y; Wang Y; Wang Y; Wu Y; Huang Y; Liu X; Zhang S; Zhong S; Li Y; Li B; Sun J; Fang S; Zhou H
Thyroid; 2023 Mar; 33(3):338-350. PubMed ID: 36617890
[No Abstract] [Full Text] [Related]
4. Insights Into Local Orbital Immunity: Evidence for the Involvement of the Th17 Cell Pathway in Thyroid-Associated Ophthalmopathy.
Fang S; Huang Y; Wang N; Zhang S; Zhong S; Li Y; Sun J; Liu X; Wang Y; Gu P; Li B; Zhou H; Fan X
J Clin Endocrinol Metab; 2019 May; 104(5):1697-1711. PubMed ID: 30517642
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms That Underly T Cell Immunity in Graves' Orbitopathy.
Fang S; Lu Y; Huang Y; Zhou H; Fan X
Front Endocrinol (Lausanne); 2021; 12():648732. PubMed ID: 33868176
[TBL] [Abstract][Full Text] [Related]
6. Disulfiram Exerts Antiadipogenic, Anti-Inflammatory, and Antifibrotic Therapeutic Effects in an
Wang X; Yang S; Ye H; Chen J; Shi L; Feng L; Wang X; Zhang T; Chen R; Xiao W; Yang H
Thyroid; 2022 Mar; 32(3):294-305. PubMed ID: 34605662
[No Abstract] [Full Text] [Related]
7. IL-17A Exacerbates Fibrosis by Promoting the Proinflammatory and Profibrotic Function of Orbital Fibroblasts in TAO.
Fang S; Huang Y; Wang S; Zhang Y; Luo X; Liu L; Zhong S; Liu X; Li D; Liang R; Miranda P; Gu P; Zhou H; Fan X; Li B
J Clin Endocrinol Metab; 2016 Aug; 101(8):2955-65. PubMed ID: 27224264
[TBL] [Abstract][Full Text] [Related]
8. Yes-Associated Protein Mediates the Transition from Inflammation to Fibrosis in Graves' Orbitopathy.
Ko J; Kim YJ; Choi SH; Lee CS; Yoon JS
Thyroid; 2023 Dec; 33(12):1465-1475. PubMed ID: 37800725
[No Abstract] [Full Text] [Related]
9. Evidence for Associations Between Th1/Th17 "Hybrid" Phenotype and Altered Lipometabolism in Very Severe Graves Orbitopathy.
Fang S; Zhang S; Huang Y; Wu Y; Lu Y; Zhong S; Liu X; Wang Y; Li Y; Sun J; Gu P; Zhou H; Fan X
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32173759
[TBL] [Abstract][Full Text] [Related]
10. Interaction Between CCR6+ Th17 Cells and CD34+ Fibrocytes Promotes Inflammation: Implications in Graves' Orbitopathy in Chinese Population.
Fang S; Huang Y; Liu X; Zhong S; Wang N; Zhao B; Li Y; Sun J; Wang Y; Zhang S; Gu P; Zhou H; Li B; Fan X
Invest Ophthalmol Vis Sci; 2018 May; 59(6):2604-2614. PubMed ID: 29847667
[TBL] [Abstract][Full Text] [Related]
11. Molecular biomarkers of Graves' ophthalmopathy.
Longo CM; Higgins PJ
Exp Mol Pathol; 2019 Feb; 106():1-6. PubMed ID: 30414981
[TBL] [Abstract][Full Text] [Related]
12. Chemokine Expression during Adipogenesis and Inflammation in Orbital Fibroblasts from Patients with Graves' Orbitopathy.
Lee CE; Choi SH; Yoon JS
Korean J Ophthalmol; 2020 Jun; 34(3):192-202. PubMed ID: 32495527
[TBL] [Abstract][Full Text] [Related]
13. Role of Proprotein Convertase Subtilisin/Kexin Type 9 in the Pathogenesis of Graves' Orbitopathy in Orbital Fibroblasts.
Lee GE; Kim J; Lee JS; Ko J; Lee EJ; Yoon JS
Front Endocrinol (Lausanne); 2020; 11():607144. PubMed ID: 33488522
[TBL] [Abstract][Full Text] [Related]
14. IL-17A Promotes RANTES Expression, But Not IL-16, in Orbital Fibroblasts Via CD40-CD40L Combination in Thyroid-Associated Ophthalmopathy.
Fang S; Huang Y; Zhong S; Zhang Y; Liu X; Wang Y; Gu P; Zhou H; Fan X
Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6123-6133. PubMed ID: 27832278
[TBL] [Abstract][Full Text] [Related]
15. Novel Roles of Chloroquine and Hydroxychloroquine in Graves' Orbitopathy Therapy by Targeting Orbital Fibroblasts.
Guo Y; Li H; Chen X; Yang H; Guan H; He X; Chen Y; Pokharel S; Xiao H; Li Y
J Clin Endocrinol Metab; 2020 Jun; 105(6):1906-17. PubMed ID: 32249902
[TBL] [Abstract][Full Text] [Related]
16. Decreased Expression of TIM-3 on Th17 Cells Associated with Ophthalmopathy in Patients with Graves' Disease.
Zhao J; Lin B; Deng H; Zhi X; Li Y; Liu Y; Bible PW; Li Q; Xu B; Wei L; Yang H; Huang D
Curr Mol Med; 2018; 18(2):83-90. PubMed ID: 29974826
[TBL] [Abstract][Full Text] [Related]
17. The Role of Adipsin, Complement Factor D, in the Pathogenesis of Graves' Orbitopathy.
Byeon HJ; Chae MK; Ko J; Lee EJ; Kikkawa DO; Jang SY; Yoon JS
Invest Ophthalmol Vis Sci; 2023 Aug; 64(11):13. PubMed ID: 37555734
[TBL] [Abstract][Full Text] [Related]
18. Dihydroartemisinin Exerts Antifibrotic and Anti-Inflammatory Effects in Graves' Ophthalmopathy by Targeting Orbital Fibroblasts.
Yang S; Wang X; Xiao W; Xu Z; Ye H; Sha X; Yang H
Front Endocrinol (Lausanne); 2022; 13():891922. PubMed ID: 35663306
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of human orbital fibroblasts cultivated from intraconal, nasal and central adipose tissues.
Kim JA; Ahn D; Kim BY; Choi YJ; Shin HJ; Jang SY
Br J Ophthalmol; 2021 Feb; 105(2):290-296. PubMed ID: 31488432
[TBL] [Abstract][Full Text] [Related]
20. Graves' orbitopathy results in profound changes in tear composition: a study of plasminogen activator inhibitor-1 and seven cytokines.
Ujhelyi B; Gogolak P; Erdei A; Nagy V; Balazs E; Rajnavolgyi E; Berta A; Nagy EV
Thyroid; 2012 Apr; 22(4):407-14. PubMed ID: 22385289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
